(fstop123/iStock) |
The Food and Drug Administration on Friday approved sales of a new drug intended to enhance sexual desire in women.
Marketed as Vyleesi, also known as bremelanotide, the medication is a shot that comes in a push pen device that can be self-administered as needed for premenopausal women who experience distress as a result of low sexual desire.
Read more: https://www.sciencealert.com/female-viagra-was-approved-by-the-fda-despite-skimpy-peer-reviewed-data
No comments:
Post a Comment